<DOC>
	<DOCNO>NCT00091286</DOCNO>
	<brief_summary>RATIONALE : Vaccines make peptide may make body build immune response kill tumor cell . PURPOSE : This clinical trial study well vaccine therapy work treat patient stage IIB , stage III , stage IV colorectal cancer .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Stage IIB , Stage III , Stage IV Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether vaccination comprise HER-2-neu carcinoembryonic antigen synthetic peptide , sargramostim ( GM-CSF ) , Montanide ISA-51 cause immune response patient stage IIB , III , IV colorectal cancer . - Determine safety regimen patient . OUTLINE : Patients receive vaccination comprise HER-2-neu carcinoembryonic antigen synthetic peptide , sargramostim ( GM-CSF ) , Montanide ISA-51 day 1 , 8 , 15 . On day 22 , patient undergo removal lymph node vaccination site drain determine whether immune system respond vaccine . PROJECTED ACCRUAL : A maximum 15 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis colorectal cancer Stage IIB , III , IV disease HLAA2 A3positive PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count &gt; 1,000/mm^3 Hemoglobin &gt; 9 g/dL Platelet count &gt; 100,000/mm^3 Hepatic Liver function test ≤ 2.5 time upper limit normal ( ULN ) Renal Creatinine ≤ 1.5 time ULN Cardiovascular No New York Heart Association class III IV heart disease Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No known suspect allergy component study drug No active connective tissue disease require medication No systemic autoimmune disease visceral involvement No uncontrolled diabetes No severe autoimmune disease No medical contraindication potential problem would preclude study compliance PRIOR CONCURRENT THERAPY : Biologic therapy More 30 day since prior immunotherapy More 30 day since prior growth factor More 30 day since prior allergy shot No prior vaccination study peptide malignancy Chemotherapy More 30 day since prior chemotherapy Endocrine therapy More 30 day since prior steroid Radiotherapy More 30 day since prior radiotherapy Surgery More 30 day since prior surgery Other At least 30 day , ≤ 24 month , since prior therapy colorectal cancer No concurrent illegal drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage IIB colon cancer</keyword>
	<keyword>stage IIIA colon cancer</keyword>
	<keyword>stage IIIB colon cancer</keyword>
	<keyword>stage IIIC colon cancer</keyword>
	<keyword>stage IVA colon cancer</keyword>
	<keyword>stage IVB colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage IIB rectal cancer</keyword>
	<keyword>stage IIIA rectal cancer</keyword>
	<keyword>stage IIIB rectal cancer</keyword>
	<keyword>stage IIIC rectal cancer</keyword>
	<keyword>stage IVA rectal cancer</keyword>
	<keyword>stage IVB rectal cancer</keyword>
</DOC>